These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 22006929

  • 1. Risk factors and other epidemiologic considerations for cervical cancer screening: a narrative review for the U.S. Preventive Services Task Force.
    Vesco KK, Whitlock EP, Eder M, Burda BU, Senger CA, Lutz K.
    Ann Intern Med; 2011 Nov 15; 155(10):698-705, W216. PubMed ID: 22006929
    [Abstract] [Full Text] [Related]

  • 2. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force.
    Whitlock EP, Vesco KK, Eder M, Lin JS, Senger CA, Burda BU.
    Ann Intern Med; 2011 Nov 15; 155(10):687-97, W214-5. PubMed ID: 22006930
    [Abstract] [Full Text] [Related]

  • 3. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
    Flores Y, Shah K, Lazcano E, Hernández M, Bishai D, Ferris DG, Lörincz A, Hernández P, Salmerón J, Morelos HPV Study Collaborators.
    Salud Publica Mex; 2002 Nov 15; 44(4):335-44. PubMed ID: 12216521
    [Abstract] [Full Text] [Related]

  • 4. Quality control of cervical cytology using a 3-type HPV mRNA test increases screening program sensitivity of cervical intraepithelial neoplasia grade 2+ in young Norwegian women-A cohort study.
    Westre B, Giske A, Guttormsen H, Wergeland Sørbye S, Skjeldestad FE.
    PLoS One; 2019 Nov 15; 14(11):e0221546. PubMed ID: 31689301
    [Abstract] [Full Text] [Related]

  • 5. Updated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents.
    Widdice LE, Moscicki AB.
    J Adolesc Health; 2008 Oct 15; 43(4 Suppl):S41-51. PubMed ID: 18809144
    [Abstract] [Full Text] [Related]

  • 6. [HPV test replaces Pap test in Uppsala].
    Olovsson M, Aarnio R, Rezapour M, Segeblad B, Sjöö EL, Wilander E.
    Lakartidningen; 2008 Oct 15; 110(13-14):695-6. PubMed ID: 23634626
    [No Abstract] [Full Text] [Related]

  • 7. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
    Wright TC, Denny L, Kuhn L, Pollack A, Lorincz A.
    JAMA; 2000 Jan 05; 283(1):81-6. PubMed ID: 10632284
    [Abstract] [Full Text] [Related]

  • 8. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A.
    J Natl Cancer Inst; 2009 Dec 02; 101(23):1612-23. PubMed ID: 19903804
    [Abstract] [Full Text] [Related]

  • 9. Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005.
    Datta SD, Koutsky LA, Ratelle S, Unger ER, Shlay J, McClain T, Weaver B, Kerndt P, Zenilman J, Hagensee M, Suhr CJ, Weinstock H.
    Ann Intern Med; 2008 Apr 01; 148(7):493-500. PubMed ID: 18378945
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer.
    Gyllensten U, Sanner K, Gustavsson I, Lindell M, Wikström I, Wilander E.
    Br J Cancer; 2011 Aug 23; 105(5):694-7. PubMed ID: 21811250
    [Abstract] [Full Text] [Related]

  • 14. hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi).
    Carozzi FM, Iossa A, Scalisi A, Sideri M, Andersson KL, Confortini M, Del Mistro A, Maina G, Ronco G, Raggi P, Schiboni ML, Zappa M, Giorgi Rossi P.
    Epidemiol Prev; 2015 Aug 23; 39(3 Suppl 1):84-90. PubMed ID: 26405780
    [Abstract] [Full Text] [Related]

  • 15. Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3.
    Zhao C, Amin M, Weng B, Chen X, Kanbour-Shakir A, Austin RM.
    Arch Pathol Lab Med; 2013 Jul 23; 137(7):942-7. PubMed ID: 23050808
    [Abstract] [Full Text] [Related]

  • 16. Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia.
    Kaufman RH, Adam E, Icenogle J, Lawson H, Lee N, Reeves KO, Irwin J, Simon T, Press M, Uhler R, Entman C, Reeves WC.
    Am J Obstet Gynecol; 1997 Jan 23; 176(1 Pt 1):87-92. PubMed ID: 9024095
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
    Duan LF, Du H, Wang C, Huang X, Qu XF, Duan XZ, Liu Y, Shi B, Zhang W, Wei LH, Belinson L, Wu RF.
    Zhonghua Fu Chan Ke Za Zhi; 2020 Oct 25; 55(10):708-715. PubMed ID: 33120484
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA.
    JAMA; 2002 Oct 09; 288(14):1749-57. PubMed ID: 12365959
    [Abstract] [Full Text] [Related]

  • 20. Summaries for patients. Results of Pap smears and human papillomavirus tests during cervical cancer screening.
    Ann Intern Med; 2008 Apr 01; 148(7):I32. PubMed ID: 18378942
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.